Recent advancements aim to improve the specificity of PSA tests. For example, the PSA velocity (rate of change over time), the free-to-total PSA ratio, and the Prostate Health Index (PHI) can provide additional information. These developments help to better distinguish between benign conditions and cancer, potentially reducing the number of unnecessary biopsies.
